For example, the inhibition of key metabolic enzymes that are upregulated in cancer, such as lactate dehydrogenase A (LDH-A) and the hexokinase isoform HK2, delays tumor progression (Krushna et al., 2013; Liu et al., 2019). Here, LDHA is linked to neoplasm.